After receiving the ethical approval in Tanzania, NeuroSolve obtained the ethical clearance in Zambia too. The ethical clearance certificate will allow to conduct medical research on Neurocysticercosis also in Zambia.

NeuroSolve is a four-year project funded by the European Commission and EDCTP3, started on May 1, 2023. The African Institutions involved are: University of Dar es Salaam (Tanzania), Sokoine University of Agriculture (Tanzania), University of Zambia (Zambia); the European Institutions are: Universiteit Ghent (Belgium) and R-Evolution Worldwide Srl – Impresa Sociale (Italy), that is also the project Coordinator. NeuroSolve is committed to fight taeniasis/Neurocysticercosis (NCC) disease in Sub-Saharan Africa.

Potrebbe essere un'immagine raffigurante testo

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

EuropeAid, from EU – a major financial resource for overseas humanitarian projects

Directorate General Development and Cooperation – EuropeAid was formed on 1 January 2011 following the merger of the EuropeAid Cooperation Office (AIDCO) with the Directorate General for Development and Relations with African, Caribbean

Read More

INTEGRATION Annual Project Meeting Y2-Rome

The INTEGRATION consortium held its annual meeting of the year 2 of the project on 6th and 7th March 2023 in Rome, Italy. During the meeting, the progress of the

Read More

Tenth EDCTP Forum October 2021: Equity in Research for Health

The Tenth biennal EDCTP Forum took place virtually, because of COVID-19 pandemic, from 17th to 21st  October 2021, hosted by the National Institute of Health (INS), Mozambique and the Health Research Centre

Read More